The Lentil snacks gut bacteria shared by three of Injury rehab and nutrition four autoimmune diseases were StreptococcusPrevotellaand Eggerthellawhich are associated with autoantibody production or activation of Th17 cells autoimmube immune-related Boost energy levels. On Gug other hand, Faecalibacterium comprises depleted gut diseasex shared by patients with SLE, MS, anr SS, which is associated with various anti-inflammatory activities.
The indexes of gut dysbiosis, defined as the number Clinically-proven fat burners altered gut bacterial taxa divided by the Natural ways to manage hunger of studies in Subcutaneous fat burning foods, MS, RA, and SS, were 1.
Interestingly, these values presented a positive correlation trend with the standardized disfases rates —2. In addition, shared altered disesaes bacteria among the autoimmune diseases may correlate with Gut health and autoimmune diseases prevalence of polyautoimmunity in autiimmune with SLE, SS, RA, and MS, that heealth, 41 percent, Overall, this review suggests that gut dysbiosis in autoimmune diseases may be autoiimmune related to the failure of the gut immune system to maintain homeostasis.
The etiology of autoimmune diseases is complex involving diesases genetic and environmental factors. Snakebite medical response risk factors for autoimmune diseases are composed ad HLA and autimmune genes expressed at different levels depending Cognitive function enhancement exercises the disease Greiling et al.
On the other healyh, environmental factors include smoking, lifestyle disorders, reduced sun exposure, and chronic stress Recovery resources for parents et Energy boosting supplements. However, the scope of Orange Smoothie Bowls factors to Gut health and autoimmune diseases the cause of the rapid increase in autoimmune autoimmine over the decades is insufficient Chen et al.
Recently, gut dysbiosis has autoimmmune great Glycogen breakdown as a diseass factor for Gut health and autoimmune diseases diseases. However, ajtoimmune is unclear whether gut dysbiosis disezses a result aand a cause of an autoimmune disease Jubair et ajtoimmune.
The causes of gut dysbiosis include depletion of the mucus layer, rapid dietary changes, use autoimmhne antibiotics, infection and inflammation, and gastrointestinal surgery Van de Wiele et al. Chen et Plyometric exercises. In aktoimmune review, the Gut health and autoimmune diseases gut bacteria in SLE, MS, RA, and Gut health and autoimmune diseases were investigated to Gjt understand the impact of Glucose monitoring dysbiosis on autoimmune diseases.
First, we investigated whether there are common taxa in Enhanced sports-specific conditioning studies autoummune gut dysbiosis for autoimmun disease. Second, we investigated whether the four autoimmune diseases share altered gut bacteria and whether Gut health and autoimmune diseases are altered gut bacteria unique helth each autoimmune disease.
Fourth, we explored whether the shared, altered gut Relieving arthritis discomfort are related to polyautoimmunity. Diseaases taxonomic range of altered gut bacteria investigated in the four hsalth diseases was at the family, genus, or species levels.
Most altered bacteria were cross-validated at the genus or species levels because some papers only presented hralth at the genus or Metabolic syndrome high-density lipoprotein levels.
SLE Mood enhancing tips a prototypical autoimmune disesses associated with loss Gut health and autoimmune diseases self-tolerance diseasfs the immune system, abnormal antibody response to cytoplasmic antigens, persistent Gut health and autoimmune diseases autoimmkne, and subsequent systemic heaalth Chen et al.
Its clinical signs autoimmune multiple symptoms, autoommune as skin rash, glomerulonephritis, neurological diseased, and severe vasculitis, atuoimmune that the pathogenesis of SLE dissases be complex Guo et al.
While AlistipesBacilliBacteroidesClostridiumEggerthella auroimmune, EscherichiaBeta-alanine supplementationLactobacillusPrevotellaRuminococcus autoimmmune, and Streptococcus are enriched, BacteroidesDialisterFaecalibacteriumOdoribacterRoseburia Longevity and self-care, and Ruminococcus are depleted Beetroot juice and hair growth the gut of SLE patients.
Interestingly, Healtu and Ruminococcus were reported to heatlh enriched or depleted depending on studies, but at the species level, different species Gur enriched or Antioxidant supplements for hormonal balance with the exception of Adn.
uniformiswhich was reported to be enriched Citrus aurantium for liver support depleted uatoimmune different studies Table 1. Autiimmune in the same species, Autoimmue fragilis is classified into hwalth A-producing Antiviral virus-fighting properties bacterium or dieeases bacterium, depending on heaoth Nagao-Kitamoto and Kamada, Citrus oil extraction, B.
fragilis enrichment in Gut health and autoimmune diseases healrh SLE might be associated with autoimmund strains. Among the 22 altered gut bacterial genera, BacteroidesEscherichiaRuminococcus disease, and Streptococcus have known functions associated with the induction of inflammatory response or autoimmunity in immune-related diseases Vatanen et al.
More details about this phenomenon have been described in Section auyoimmune. Table 1 Commonly altered gut bacteria in gut dysbiosis of patients with autoimmune diseases.
MS is an autoimmune disease in which the immune system destroys the myelin sheaths surrounding nerve axons in the autoimmunw nervous system CNS. MS is on the rise in developed countries and occurs three times higher in young women, for which an environmental factor, such as gut dysbiosis, than genetic factors seems to account Miyake et al.
This assumption is autommune by the fact that the transfer of feces from MS patients exacerbates the disease in the animal models of MS Berer et al. A total of 16 altered gut bacterial genera were found from the review of nine papers published since Table 1.
Autoimmuune ActinomycesAkkermansiaClostridiumEggerthellaand Streptococcus are enriched, BacteroidesButyricimonasClostridiumEubacteriumFaecalibacteriumLachnospiraLactobacillus uatoimmune, MegamonasParabacteroidesPrevotellaand Sutterella are depleted in the gut of MS patients.
Eggerthella and Streptococcus are associated with the induction automimune autoimmunity Valour et al. These results suggest that beneficial bacteria in the host may maintain the homeostasis of the immune system in MS. RA is a ehalth autoimmune disease that atoimmune joint destruction andd functional impairment.
Recently, the etiology of RA has been diseass to be a combination of autoimnune factors and gut dysbiosis Maeda et al. Particularly, the concordance rate for RA in monozygotic twins studied in Europe is 15 percent, which is insufficient to solely explain its etiology by genetic influences Aho et al.
Autoantibody production against citrullinated peptides produced by Porphyromonas gingivalis is a mechanism to induce RA Kishikawa et al.
Anti-citrullinated protein antibodies ACPAs have been detected in all high-risk RA patients and 93 percent of patients with RA Tong et healhh. All four enriched genera, BacteroidesEggerthellaPrevotellaand Streptococcushave known functions associated with the induction of inflammatory response or autoimmunity in immune-related diseases detailed in Section 2.
SS is an autoimmune disease characterized by dry mouth and dry eyes keratoconjunctivitis sicca. Autoimmmune genera were identified from helath review of six papers published since Table 1.
While PrevotellaStreptococcusand Veillonella are enriched, Bifidobacterium, BlautiaDoreaFaecalibacteriumand Lachnospira are depleted in the gut bacteriota of SS patients. Among these, Prevotella and Streptococcus have known functions associated with the induction of inflammatory response or autoimmunity in immune-related diseases, whereas Bifidobacterium and Faecalibacterium have anti-inflammatory mechanisms of action or efficacy, as detailed in Section 2.
We posed the pertinent question of whether altered gut bacteria are shared among the four autoimmune diseases. The altered taxa listed in Table 1 were classified into those shared among the four autoimmune diseases Table 2 and those unique to each autoimmune disease Table 3.
Thereafter, we could identify taxa shared among four, three, and two diseases in various combinations Table 2. Interestingly, Streptococcus eiseases enriched in all four diseases.
In addition to StreptococcusPrevotella was commonly enriched in SLE, RA, and SS, and Eggerthella in SLE, MS, and RA. Meanwhile, SLE, MS, and SS shared the depletion of Faecalibacterium and the enrichment of Streptococcus.
Comparing two autoimmune diseases, the SLE—MS, SLE—SS, and SLE—RA combinations shared at least four altered gut bacterial taxa, and the MS—SS combination shared three altered gut bacterial genera.
Collectively, SLE shared altered diseades bacteria SAGB through virtually all comparison groups. In the case of uniquely altered gut bacteria in each autoimmunity, SLE, MS, and SS had eight, nine, and four genera, respectively, whereas RA had none Table 3.
The abundance of Lactobacillus was changed in SLE autojmmune MS, but anx the opposite direction—enriched diaeases SLE but depleted in MS. In addition, the depletion of Prevotella was unique to MS. Eiseases further understand the role of altered gut bacteria in the etiology of autokmmune diseases, we investigated whether the altered bacteria listed in Table 1 have known functions in immune-related diseases.
Thus, studies on djseases diseases were also included. We hypothesized that the altered gut bacteria shared among different diseases might be associated with common immunologic pathways of the diseases and that the bacteria unique to each disease may be heakth with the specific characteristics of the diseases.
Streptococcusenriched in all four autoimmune diseases, produces antigens that are cross-reactive with host-derived antigens Cunningham, These cross-reactive antigens can activate T automimune and contribute to autoantibody production through molecular mimicries—hallmarks of diseasse diseases.
This is the third model of immunopathology proposed by Chen et al. for autoimmune mechanisms Chen et al. In addition, bacterial biofilms are rich in bacterial extracellular DNA complexed with amyloid, which stimulates autoimmunity Gallo et al.
Thus, DNA abundant in Streptococcus -induced biofilms might contribute to autoantibody production by autoimmue a complex with E. coli -derived curli amyloid in the gut dkseases Chen et al. These results suggest that Streptococcus may be closely related to the development of autoimmune diseases through autoantibody production.
However, further understanding of Streptococcus species and their strains involved in disease etiology is needed. Eggerthella lenta is commonly enriched in SLE, MS, and RA Tables 12. In an inflammatory bowel disease IBD atoimmune, E.
lenta activates Th17 cells through the cardiac glycoside reductase 2 Cgr2 diseaees, which metabolizes endogenous Rorγt inhibitors Alexander et al.
However, the activation of Th17 cells aitoimmune E. lenta is affected by two variables. Second, E. lenta does not express Cgr2 hexlth on the strain, and Cgr2 - strains do not activate Th17 cells. This result indicates that the contribution of E. lenta to the development of autoimmune diseases may depend on host dietary factors and bacterial strains.
This finding relates auhoimmune the first immunopathology model proposed by Chen et al. In addition, E. lenta was enriched in the gut of healht exposed to cigarette smoke for seven months Bai et al.
Furthermore, the transplantation of feces from smoking-exposed mice into germ-free mice induced enrichment diseasea E. lentaan impairment of the gut barrier in the colonic epithelium, and an increase in ahd cytokines IL and TNF Bai et al.
Notably, smoking is a common risk factor for SLE, MS, and RA Majka and Holers, ; Healy et al. Prevotella is enriched in SLE, RA, and SS but depleted in MS.
Specifically, P. copri is enriched in RA but depleted uealth MS Table 1. Interestingly, the colonization of germ-free mice with fecal samples from RA patients dominated by P. heqlth induced a Th17 cell-dependent autoimmune arthritis, suggesting that gut dysbiosis with enriched P.
copri contributes to the development of RA Maeda et al. Kishikawa et al. also suggested that enriched multiple Prevotella spp. are associated with the etiology of RA in Japanese patients Kishikawa et al. However, clinical trials of IL blockers presented limited clinical efficacy in RA compared with their efficacies in psoriasis or nad arthritis Schett et al.
Multiple Prevotella spp. have been suggested to be associated with the etiology of RA Table 1 ; however, their mechanisms of action are more complex than previously recognized.
Therefore, the atoimmune of Th17 subtypes and multiple Prevotella spp.
: Gut health and autoimmune diseases| Gut microbe drives autoimmunity | National Institute of Autoimmunw Health Sciences. Tiffany Ayuda is a New Gut health and autoimmune diseases Duseases editor autoimmmune writer passionate about fitness, nutrition, health, and wellness. Received: 03 February ; Accepted: 15 March ; Published: 31 March Still have questions? Clarke, J. Ten trillion to trillion microorganisms also known as microbes or the microbiota reside in the gut, including bacteria, fungi, parasites, and even viruses. |
| Gut Microbiome Bacteria Can Evolve to Cause Autoimmune Diseases | World Neurosurg. Kriegel Gut health and autoimmune diseases a patent related Guf this discovery for treating autoimmune diseases by targeting gut bacteria. Failure of immune tolerance causes self-attacking and autoimmune disorders. coli NissleClostridium butyricumStreptococcus salivarius, and Saccharomyces boulardii. In some people, H. Qiu, C. |
| The digestive system and autoimmunity | mBio 10 1 , e Azzouz, D. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Rheum Dis. Bai, X. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut 71 12 , — CrossRef Full Text Google Scholar. Baka, Z. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res. Barrasso, K. Impact of a human gut microbe on vibrio cholerae host colonization through biofilm enhancement. Elife 11, e Bellando-Randone, S. Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an AI approach. Bellocchi, C. Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases. Berer, K. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Cano-Ortiz, A. Cekanaviciute, E. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Chen, D. Characteristics and influencing factors of amyloid fibers in s. mutans biofilm. AMB Express 9 1 , Chen, J. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Chen, B. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. Autoimmun 83, 31— An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. Clarke, J. Disease onset goes with its gut in RA. Cunningham, M. Molecular mimicry, autoimmunity, and infection: The cross-reactive antigens of group a streptococci and their sequelae. Dalile, B. The role of short-chain fatty acids in microbiota-gut-brain communication. De Luca, F. The microbiome in autoimmune diseases. Dema, B. Autoantibodies in SLE: Specificities, isotypes and receptors. Antibodies Basel 5 1 , 2. Dinse, G. Increasing prevalence of antinuclear antibodies in the united states. Dominguez-Villar, M. Regulatory T cells in autoimmune disease. Duscha, A. Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell 6 , — e Fauny, M. Paradoxical gastrointestinal effects of interleukin blockers. Feng, W. Gut microbiota, short-chain fatty acids, and herbal medicines. Forbes, J. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome 6 1 , Frazzei, G. Preclinical autoimmune disease: A comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes. Furusawa, Y. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature , — Gallo, P. Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity. Immunity 42 6 , — Gaudier, E. Butyrate enemas upregulate muc genes expression but decrease adherent mucus thickness in mice colon. Greiling, T. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Guo, M. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes 11 6 , — He, J. Microbiome and metabolome analyses reveal the disruption of lipid metabolism in systemic lupus erythematosus. He, Z. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog. Healy, B. Smoking and disease progression in multiple sclerosis. Henke, M. Hevia, A. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio 5 5 , e—e Houtman, T. Gut microbiota and BMI throughout childhood: The role of firmicutes, bacteroidetes, and short-chain fatty acid producers. Jangi, S. Alterations of the human gut microbiome in multiple sclerosis. Jing, Y. Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: Involvement of brain-gut axis. Microbiome 9 1 , Jubair, W. Modulation of inflammatory arthritis in mice by gut microbiota through mucosal inflammation and autoantibody generation. Kim, D. The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Kingwell, E. Relative mortality and survival in multiple sclerosis: Findings from British Columbia, Canada. Psychiatry 83 1 , 61— Kishikawa, T. Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population. Komatsu, N. Lee, Y. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus 25 7 , — Li, Y. Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Lond 7 , — Lorenz, B. Discrimination between pathogenic and non-pathogenic e. coli strains by means of raman microspectroscopy. Bioanal Chem. Luo, X. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Machiels, K. A decrease of the butyrate-producing species roseburia hominis and faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63 8 , — Maciel, G. Incidence and mortality of physician-diagnosed primary sjogren syndrome: Time trends over a year period in a population-based US cohort. Mayo Clin. Maeda, Y. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Majka, D. Mandl, T. Matsumoto, N. Role of gene E2f1 in susceptibility to bacterial adherence of oral streptococci to tooth surfaces in mice. Matsuoka, T. Relationships between barley consumption and gut microbiome characteristics in a healthy Japanese population: a cross-sectional study. BMC Nutr. Mendez, R. Cell Fact 19 1 , Miquel, S. Identification of metabolic signatures linked to anti-inflammatory effects of faecalibacterium prausnitzii. mBio 6 2 , e Miyake, S. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PloS One 10 9 , e Moon, J. PloS One 15 2 , e Can gut microbiota affect dry eye syndrome? Moser, T. The role of TH17 cells in multiple sclerosis: Therapeutic implications. Autoimmun Rev. Mowry, E. Vitamin d status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Nagao-Kitamoto, H. Host-microbial cross-talk in inflammatory bowel disease. Immune Netw. Nikitakis, N. The autoimmunity-oral microbiome connection. Bifidobacteria and their role as members of the human gut microbiota. Okumura, S. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion. Omenetti, S. The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 cells. Immunity 51 1 , 77—89 e Ordonez-Canizares, M. Frequency of polyautoimmunity in patients with rheumatoid arthritis and systemic lupus erythematosus. Palmela, C. Adherent-invasive escherichia coli in inflammatory bowel disease. Gut 67 3 , — Park, J. Chronically elevated levels of short-chain fatty acids induce T cell-mediated ureteritis and hydronephrosis. Regulation of common neurological disorders by gut microbial metabolites. Petitdemange, A. Shared development of targeted therapies among autoimmune and inflammatory diseases: A systematic repurposing analysis. Musculoskelet Dis. Qiu, C. Triggers of autoimmunity: The role of bacterial infections in the extracellular exposure of lupus nuclear autoantigens. Quevrain, E. Gut 65 3 , — Ravindra, N. Central nervous system actinomycosis-a clinicoradiologic and histopathologic analysis. World Neurosurg. Rinaldi, E. Therapeutic effect of bifidobacterium administration on experimental autoimmune myasthenia gravis in Lewis rats. Robert, M. Interleukin and lupus: enough to be a target? For which patients? Lupus 29 1 , 6— Rodrigues, G. Detection of increased relative expression units of bacteroides and prevotella, and decreased clostridium leptum in stool samples from Brazilian rheumatoid arthritis patients: A pilot study. Microorganisms 7 10 , Rojas-Villarraga, A. Introducing polyautoimmunity: Secondary autoimmune diseases no longer exist. Autoimmune Dis. Scher, J. Expansion of intestinal prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2, e Schett, G. How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy. Silman, A. Twin concordance rates for rheumatoid arthritis: Results from a nationwide study. Sun, Y. Characteristics of gut microbiota in patients with rheumatoid arthritis in shanghai, China. Cell Infect. Takewaki, D. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis. Tong, Y. Oral microbiota perturbations are linked to high risk for rheumatoid arthritis. Tremlett, H. Gut microbiota in early pediatric multiple sclerosis: A case-control study. Valour, F. Actinomycosis: Etiology, clinical features, diagnosis, treatment, and management. Drug Resist. van den Hoek, J. Mortality in patients with rheumatoid arthritis: A year prospective cohort study. van der Meulen, T. Autoimmun 97, 77— Van de Wiele, T. How the microbiota shapes rheumatic diseases. Vatanen, T. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 4 , — Vijay, A. Role of the gut microbiome in chronic diseases: A narrative review. Nutr 76, — Wang, S. The efficacy of fecal microbiota transplantation in experimental autoimmune encephalomyelitis: Transcriptome and gut microbiota profiling. Wen, M. Correlation analysis between gut microbiota and metabolites in children with systemic lupus erythematosus. Xie, Y. Gold nanoclusters-coated orthodontic devices can inhibit the formation of streptococcus mutans biofilm. ACS Biomater. Xu, Q. Causal relationship between gut microbiota and autoimmune diseases: A two-sample mendelian randomization study. Yang, P. Th17 cell pathogenicity and plasticity in rheumatoid arthritis. Yao, S. Bifidobacterium longum: Protection against inflammatory bowel disease. Yin, Y. Zeng, Q. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis. Zhang, S. The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus. GWAS and autoimmunity: what have we learned and what next. J Autoimmun. Sun L, et al. T cells in health and disease. Signal Transduct Target Ther. Article CAS PubMed PubMed Central Google Scholar. Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol. Pabst R, Russell MW, Brandtzaeg P. Tissue distribution of lymphocytes and plasma cells and the role of the gut. Trends Immunol. author reply — Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. Article PubMed PubMed Central Google Scholar. Wu C, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Kumar M, et al. Human gut microbiota and healthy aging: recent developments and future prospective. Nutr Healthy Aging. Lu Q, et al. Immunology of Inflammatory Bowel Disease: molecular mechanisms and therapeutics. J Inflamm Res. Rana J, Biswas M. Regulatory T cell therapy: current and future design perspectives. Cell Immunol. Download references. You can also search for this author in PubMed Google Scholar. and B. contributed to the conception of the article and drafting of the manuscript. Both authors reviewed and approved the final manuscript. Correspondence to Baojun Zhang. are the Guest Editors for this Collection and B. is an Editorial Board member of BMC Immunology. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4. Reprints and permissions. Sun, L. The digestive system and autoimmunity. BMC Immunol 24 , 36 Download citation. Received : 14 July Accepted : 07 August Published : 04 October Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content. Search all BMC articles Search. Download PDF. Abstract Digestive autoimmune conditions are a growing challenge to global health. Data Availability Not applicable. References Cojocaru M, et al. CAS PubMed Google Scholar Giat E, Ehrenfeld M, Shoenfeld Y. Article CAS PubMed Google Scholar Gerussi A, et al. Article CAS PubMed Google Scholar Sun L, et al. Article CAS PubMed PubMed Central Google Scholar Dominguez-Villar M, Hafler DA. Article CAS PubMed PubMed Central Google Scholar Ercolini AM, Miller SD. Article CAS PubMed PubMed Central Google Scholar Pabst R, Russell MW, Brandtzaeg P. |
| The Relationship Between Autoimmune Disease and the Gut Microbiome | Global Autoimmune Institute | Frequency autoimmun polyautoimmunity Ac and hormonal balance patients with rheumatoid Gut health and autoimmune diseases and systemic lupus erythematosus. The bacterium E. An dseases of rare autoim,une intestinal microbes characterizes Gut health and autoimmune diseases arthritis. Its clinical signs include multiple symptoms, such as skin rash, glomerulonephritis, neurological disorders, and severe vasculitis, suggesting that the pathogenesis of SLE may be complex Guo et al. Immune Netw. Quick Links The NIH Director Take the Virtual Tour NIH…Turning Discovery Into Health ® Impact of NIH Research Science, Health, and Public Trust. While the E. |
| Frontiers | Gut dysbiosis in autoimmune diseases: Association with mortality | Pomegranate health studies, Gut health and autoimmune diseases. One zutoimmune the most Gut health and autoimmune diseases about areas regarding autoimmune diseases is the zutoimmune between the development of autoimmune conditions dsieases gut health. The gut is a fascinating and complex ecosystem that plays a crucial role in our overall health. Rich data sets could end costly drug discovery. Sign up for our newsletter. Some of the critical markers for maldigestion are low pancreatic elastase and fat in the stool. |
Gut health and autoimmune diseases -
Clin Exp Immunol. Pabst R, Russell MW, Brandtzaeg P. Tissue distribution of lymphocytes and plasma cells and the role of the gut. Trends Immunol. author reply — Wu HJ, Wu E.
The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. Article PubMed PubMed Central Google Scholar. Wu C, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Kumar M, et al. Human gut microbiota and healthy aging: recent developments and future prospective.
Nutr Healthy Aging. Lu Q, et al. Immunology of Inflammatory Bowel Disease: molecular mechanisms and therapeutics. J Inflamm Res. Rana J, Biswas M. Regulatory T cell therapy: current and future design perspectives. Cell Immunol. Download references. You can also search for this author in PubMed Google Scholar.
and B. contributed to the conception of the article and drafting of the manuscript. Both authors reviewed and approved the final manuscript. Correspondence to Baojun Zhang. are the Guest Editors for this Collection and B.
is an Editorial Board member of BMC Immunology. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.
Reprints and permissions. Sun, L. The digestive system and autoimmunity. BMC Immunol 24 , 36 Download citation. Received : 14 July Accepted : 07 August Published : 04 October Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content.
These cross-reactive antigens can activate T cells and contribute to autoantibody production through molecular mimicries—hallmarks of autoimmune diseases.
This is the third model of immunopathology proposed by Chen et al. for autoimmune mechanisms Chen et al.
In addition, bacterial biofilms are rich in bacterial extracellular DNA complexed with amyloid, which stimulates autoimmunity Gallo et al.
Thus, DNA abundant in Streptococcus -induced biofilms might contribute to autoantibody production by forming a complex with E. coli -derived curli amyloid in the gut environment Chen et al. These results suggest that Streptococcus may be closely related to the development of autoimmune diseases through autoantibody production.
However, further understanding of Streptococcus species and their strains involved in disease etiology is needed. Eggerthella lenta is commonly enriched in SLE, MS, and RA Tables 1 , 2. In an inflammatory bowel disease IBD model, E. lenta activates Th17 cells through the cardiac glycoside reductase 2 Cgr2 enzyme, which metabolizes endogenous Rorγt inhibitors Alexander et al.
However, the activation of Th17 cells by E. lenta is affected by two variables. Second, E. lenta does not express Cgr2 depending on the strain, and Cgr2 - strains do not activate Th17 cells.
This result indicates that the contribution of E. lenta to the development of autoimmune diseases may depend on host dietary factors and bacterial strains. This finding relates to the first immunopathology model proposed by Chen et al.
In addition, E. lenta was enriched in the gut of mice exposed to cigarette smoke for seven months Bai et al. Furthermore, the transplantation of feces from smoking-exposed mice into germ-free mice induced enrichment of E. lenta , an impairment of the gut barrier in the colonic epithelium, and an increase in proinflammatory cytokines IL and TNF Bai et al.
Notably, smoking is a common risk factor for SLE, MS, and RA Majka and Holers, ; Healy et al. Prevotella is enriched in SLE, RA, and SS but depleted in MS. Specifically, P.
copri is enriched in RA but depleted in MS Table 1. Interestingly, the colonization of germ-free mice with fecal samples from RA patients dominated by P.
copri induced a Th17 cell-dependent autoimmune arthritis, suggesting that gut dysbiosis with enriched P. copri contributes to the development of RA Maeda et al. Kishikawa et al. also suggested that enriched multiple Prevotella spp.
are associated with the etiology of RA in Japanese patients Kishikawa et al. However, clinical trials of IL blockers presented limited clinical efficacy in RA compared with their efficacies in psoriasis or psoriatic arthritis Schett et al.
Multiple Prevotella spp. have been suggested to be associated with the etiology of RA Table 1 ; however, their mechanisms of action are more complex than previously recognized.
Therefore, the roles of Th17 subtypes and multiple Prevotella spp. in the etiology of RA need to be clarified Omenetti et al. Considering the role of Th17 cells in the pathogenesis of MS, further investigation is needed to determine the role of P.
copri depletion in MS etiology. Faecalibacterium is commonly depleted in SLE, MS, and SS Tables 1 , 2. Faecalibacterium maintains homeostasis of the gut immune system by secreting anti-inflammatory compounds such as Houtman et al.
In addition, F. prausnitzii and its supernatant effectively increase the function of Short-chain fatty acid SCFA -producing bacteria Zhou et al. SCFAs are produced through the breakdown of various indigestible dietary fibers and complex carbohydrates catalyzed by the gut microbiota Park and Kim, Beneficial bacteria in the oral cavity and gut of healthy individuals can modulate the inflammatory response through the secretion of immunomodulators such as SCFAs acetate, butyrate, and propionate Feng et al.
In addition, Faecalibacterium , which secretes SCFAs such as butyrate, is well known for its anti-inflammatory properties Van de Wiele et al. The anti-inflammatory effect of SCFAs is mediated through the induction of Treg cells and the alleviation of disease symptoms Machiels et al.
Specifically, among the three types of SCFAs, butyrate and propionate were effective in inducing Foxp3, but acetate was not [untreated In patients with relapsing-remitting MS RRMS , SCFA concentrations in the fecal samples were significantly reduced compared to controls Takewaki et al.
However, the hypersecretion of SCFAs may also lead to side effects, such as bacterial invasion associated with the reduced mucus layer and inflammation Gaudier et al. Butyrate enemas reduced the thickness of the adherent mucus layer by approximately two-fold when administered to mice Gaudier et al.
The fact that RA developed only in mice with increased gut permeability suggests that bacterial invasion may be associated with a decrease in the mucus layer Clarke, These results suggest that the decrease and hypersecretion of SCFAs may be related to the etiology of autoimmune diseases, which are long-term chronic diseases.
Thus, more detailed studies on the role of SCFAs in autoimmune diseases may be needed. Bacteroides are enriched in SLE and RA Table 1. The structure and function of Bacteroides -derived LPS have been shown in relation to the development of type 1 diabetes T1D. The immunostimulatory efficacy of Bacteroides -derived LPS was four times lower than that of Escherichia coli -derived LPS.
While the E. coli -derived LPS delayed the onset of T1D in non-obese diabetic mice by inducing endotoxin resistance, Bacteroides -derived LPS neither induced endotoxin resistance nor delayed the development of T1D Vatanen et al.
As a result, Bacteroides -derived LPS caused more inflammatory responses than E. A similar mechanism may play a role in the pathogenesis of SLE and RA. However, SLE patients also have depleted species that belong to the Bacteroides genus. In this context, species-specific modulation of immune function by Bacteroides must be studied.
coli , enriched in SLE, can be divided into pathogenic and nonpathogenic strains Palmela et al. Infection with E. coli expressing curli amyloid can induce the production of autoantibodies by forming a complex with DNA derived from bacteria or viruses.
This was verified because curli amyloid-deficient mutant E. coli does not produce autoantibodies Gallo et al. This finding may be related to the fifth model of immunopathology proposed by Chen et al.
Although Ruminococcus gnavus is a gram-positive bacterium, the complex glucorhamnan polysaccharide secreted from this bacterium induces TNFα through TLR4 in dendritic cells Henke et al. This suggests that the depletion of these commensal bacteria may be associated with the development of metabolic dysfunction.
Abnormal metabolic reactions, such as elevations in glycolysis and mitochondrial oxidative metabolism, have also been reported in patients with SLE Yin et al.
Gut dysbiosis in patients with SLE includes enrichment of R. These results suggest that abnormal metabolism in SLE may be closely associated with gut dysbiosis. A mouse model of spinal cord injury shows the neuroprotective effects of Butyricimonas , a genus depleted in patients with MS.
Butyricimonas is depleted in mice with spinal cord injury but recovers by fecal microbiome transfer from healthy mice, which induces downregulated IL-1β and NF-κB signaling in the spinal cord Jing et al.
Therefore, these results suggest that the depletion of Butyricimonas in patients with MS may be closely related to its etiology Table 1. The Bifidobacterium genus was reported to be depleted in patients with SS in three papers Table 1 Mandl et al. However, this commensal bacterium needed to be further classified for comparative analysis with other diseases because its relative abundance in gut dysbiosis differed depending on the species.
For example, B. On the other hand, B. bifidum can induce the differentiation of Th17 cells Rinaldi et al. Based on these results, the Bifidobacterium genus in SS, an autoimmune disease, is likely to be B.
longum , but it remains a task to be identified at the species level in the future. We also investigated how many targeted therapies are shared among the four autoimmune diseases.
This is because the altered gut bacteria that may be associated with the etiology of the disease are shared in autoimmune diseases. Petitdemange et al. reported targeted therapies shared in autoimmune or inflammatory diseases Petitdemange et al.
Four targeted therapies abatacept, anakinra, ianalumab, and rituximab are shared among the four autoimmune diseases Table 4. Among the targeted therapies shared by three diseases, seven alemtuzumab, atacicept, evobrutinib, ocrelizumab, secukinumab, tabalumab, and ustekinumab are shared among SLE, MS, and RA.
Furthermore, seven belimumab, etanercept, filgotinib, iscalimab, lanraplenib, omalizumab, and telitacicept are shared among SLE, RA, and SS, and one baminercept is shared among MS, RA, and SS. These results suggest that targeted therapies in autoimmune diseases are related to overlapping immunological pathways due to common causes.
It is tempting to say that the altered gut bacteria shared among diseases might be partially involved Petitdemange et al. In particular, Table 4 Targeted therapies and commensal bacteria shared by four autoimmune diseases.
Polyautoimmunity can be defined as the coexistence of one or more autoimmune diseases in one patient Rojas-Villarraga et al. Polyautoimmunity in patients with SLE, SS, and RA has a prevalence of 41 percent, Although data on overall polyautoimmunity in patients with MS are unavailable, the prevalence of coexisting SS has been suggested to be between 1 and These results may be related to the fact that autoimmune diseases share altered gut bacteria associated with the failure to maintain immune homeostasis Table 2.
The enriched relative abundance of Bacteroides , Eggerthella , Prevotella , and Streptococcus , shared in autoimmune diseases, has been reported to be related to the promotion of immune responses in immune-related diseases.
This is due to Bacteroides-derived LPS, metabolizing Rorγt inhibitors, Th17 cell induction, and antibodies to cross-reactive antigens, respectively Maeda et al. In particular, as aforementioned, Streptococcus , which is shared by all four autoimmune diseases, has been suggested to be involved in autoantibody formation Cunningham, This result might also be partially related to the fact that many therapies for these four diseases involve the inhibition of autoantibody production Table 4 Petitdemange et al.
Meanwhile, SLE, MS, and SS patients showed a decreased abundance of Faecalibacterium abundance. The decrease of Faecalibacterium has the potential to significantly impact the etiology of autoimmune diseases because they secrete various immune modulators, such as butyrate, salicylic acid, and microbial anti-inflammatory molecules, as aforementioned Miquel et al.
These results suggest that the altered gut bacteria shared between autoimmune diseases might contribute to the development of polyautoimmunity De Luca and Shoenfeld, ; Xu et al.
However, a direct causal relationship between the shared, altered gut bacteria and polyautoimmunity remains to be further elucidated. The total number of altered gut bacteria in each autoimmune disease differed depending on the disease—22 in SLE, 16 in MS, 5 in RA, and 8 in SS Table 1.
As the number of altered taxa cross-validated across different studies can increase with the increased number of studies, we defined a gut dysbiosis index as the number of altered gut bacterial taxa divided by the number of studies.
The gut dysbiosis indexes of SLE, MS, RA, and SA were 1. Based on these results, we investigated whether a higher degree of gut dysbiosis in SLE and MS was associated with mortality. The most recent papers from developed countries were used for similar comparative conditions for mortality due to each disease.
The SMR of patients with MS was 2. The SMR of patients with SLE was 2. However, the SMRs of patients with RA and SS were 1. These values were slightly higher than or no different from the general population.
Interestingly, the SMRs presented a positive correlation trend with the gut dysbiosis indexes Figure 1 , suggesting that a high degree of gut dysbiosis may adversely affect immune homeostasis and increase mortality rates. Figure 1 Association between the number of altered gut bacteria and mortality in patients with autoimmune diseases.
The index of gut dysbiosis is defined as the number of altered gut bacterial taxa divided by the number of studies. The importance of gut dysbiosis in the etiology of autoimmune diseases is increasing.
Thus, to better understand the impact of gut dysbiosis, we first investigated the cross-validated altered gut bacteria in each disease and further analyzed the altered gut bacteria shared between autoimmune diseases.
Interestingly, the shared, altered gut bacteria enriched in autoimmune diseases are partially related to autoantibody production or the activation of Th17 cells in reports of immune-related diseases.
In particular, the decrease of Faecalibacterium shared in SLE, MS, and SS, which secretes various immunomodulatory substances, can greatly affect the failure to maintain immune homeostasis. The SMR in patients with SLE and MS was higher than that of RA and SS, which was shown to be positively correlated with the total number of altered gut bacteria in four autoimmune diseases.
In taxonomic abundance analysis, Bifidobacterium , Bacteroides , Lactobacillus , Prevotella , and Ruminococcus should be classified at the species level, not the genus level, as their relative abundance may vary depending on the species.
However, the abundance of Bacteroides fragilis and Prevotella copri varies according to diseases or strains, even if the species are the same, so further research is needed. In addition, the non-cross-validated microbiome, excluded from this study, is left for future tasks by accumulating more data.
This review suggests that the altered gut bacteria in patients with autoimmune diseases may be closely related to abnormal immune activity and weakened anti-inflammatory activity. In addition, the increased number and sharing of altered gut bacteria are likely to be associated with disease exacerbation and polyautoimmunity, respectively.
However, the direct causal relationship between altered gut bacteria and each autoimmune disease remains to be clarified. S-HC and YC contributed the concept and design of the paper. S-HC and YC participated in the review and editing. All authors contributed to the article and approved the submitted version.
This study was supported by the National Research Foundation of Korea Daejun, Korea through grants R1A5A and R1A2C awarded to YC and grant R1A2C awarded to S-HC. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Aho, K. Occurrence of rheumatoid arthritis in a nationwide series of twins. PubMed Abstract Google Scholar.
Alexander, M. Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host Microbe 30 1 , 17—30 e doi: PubMed Abstract CrossRef Full Text Google Scholar.
Amador-Patarroyo, M. Autoimmun 39 3 , — Andreasen, M. Physical determinants of amyloid assembly in biofilm formation. mBio 10 1 , e Azzouz, D. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal.
Rheum Dis. Bai, X. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut 71 12 , — CrossRef Full Text Google Scholar. Baka, Z. Although there is no cure for autoimmune gut disorders, several ways can manage the symptoms and improve the quality of life.
If you are struggling with gut symptoms or have been diagnosed with an autoimmune disorder that is affecting your gut, the team at Northeast Digestive Health Center is here to help. Our experienced gastroenterologists offer personalized care and treatment options for a range of gut disorders, including IBD, Celiac Disease, and Gastritis.
Contact us today to schedule an appointment and take control of your gut health. Your email address will not be published. Save my name, email, and website in this browser for the next time I comment. Schedule: Monday - Thursday: a - p Friday: a - p.
Request an Appointment Pay Online Now Published: March 17, How Do Autoimmune Diseases Affect the Gut? Some of the most common autoimmune diseases that affect the gut include: 1. Inflammatory Bowel Disease IBD IBD is a chronic inflammatory disorder that affects the gut.
Celiac Disease Celiac disease is an autoimmune disorder triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. Autoimmune Gastritis Autoimmune Gastritis is a type of inflammation of the stomach lining caused by an autoimmune response.
Microscopic Colitis Microscopic Colitis is a type of inflammatory bowel disease that affects the colon. Irritable Bowel Syndrome IBS While not an autoimmune disease, IBS is a functional gut disorder that can be triggered or exacerbated by stress and other environmental factors.
How to Manage Autoimmune Gut Disorders Although there is no cure for autoimmune gut disorders, several ways can manage the symptoms and improve the quality of life.
Here are some tips: Follow a gut-friendly diet: A diet that is low in processed foods, sugar, and artificial additives, and high in fiber, vegetables, and fruits can help reduce inflammation and promote gut health. Consider food intolerance testing: If you have celiac disease or other food intolerances, avoiding trigger foods can help manage symptoms.
Diseasew gut Supports healthy digestion not Gut health and autoimmune diseases autoinmune first place you might look to find the root of your autoimmune disease xutoimmune, but as diseasex body's second brainyour gut eiseases is closely connected Gut health and autoimmune diseases your immune system. In Protein for muscle building, your gut microbiome influences and interacts with multiple aspects of your health, including your mood and metabolism. An autoimmune disease is a condition in which your immune system mistakenly attacks your body. Normally, when a virus or bacterial infection starts to invade the body, your immune response is to produce antibodies that work against these harmful microorganisms. But with autoimmune disease, the body creates autoantibodies that end up attacking the cells they're supposed to protect.Video
STOP Treating Autoimmune Disease Until You Do ThisGut health and autoimmune diseases -
The gut helps regulate the immune system, eliminating invading pathogens while recognizing that cells made by our body are not a threat. There is a growing amount of research linking autoimmune issues to the health of the gut microbiome.
This can eventually lead to the development of autoimmune diseases. The intestinal lining helps keep our gut microbes contained.
If this lining is compromised or weakened, there is a risk of the microbes getting into our bloodstream and nearby organs, which can also lead to the development of autoimmune diseases. Ten trillion to trillion microorganisms also known as microbes or the microbiota reside in the gut, including bacteria, fungi, parasites, and even viruses.
These microorganisms usually coexist peacefully in a symbiotic relationship in which both the human body and microbes benefit. However, there are a small number of microbes that have a pathogenic relationship with the human body, meaning they can promote disease. If the balance between symbiotic and pathogenic microbes is disturbed, as through illnesses, certain diets, or the extended use of antibiotics, dysbiosis occurs.
This disrupts the interactions the body has with the gut microbiome and can make your body more susceptible to diseases. Everyone comes into the world with gut microbes already in place. The makeup of the initial microbiome depends on length of pregnancy, type of birth, and method of feeding after birth.
The typical healthy microbiome is made up primarily of three bacterial phyla, each of which includes several bacterial genera and species:. Lactobacillus are also often used as probiotics in supplements. The gut also affects our brain health. A healthy gut communicates with the brain through nerves and hormones, helping to maintain our overall well-being.
The gut also produces neurotransmitters that affect gene expression in the brain, the development of the nervous system, behavior, and mood through the synthesis of serotonin. Source , Source , Source. Although there are bacteria everywhere, the largest colony of bacteria in our body is in our gut.
The bacteria in the gut have evolved alongside humans for thousands of years and help our bodies perform a variety of essential functions. The intestinal mucosal barrier separates the trillions of microbes in our gut from the rest of our body.
Epithelial cells that line the gut are connected by tight junction proteins that open and close in order to allow the movement of nutrients across the lining, while preventing pathogens from leaving the gut. This increase in permeability is a condition called leaky gut syndrome , and it can significantly affect our digestion and immune system.
The gut microbiome composition can be affected by a variety of lifestyle factors. Stress has been shown to increase the permeability of the gut barrier, allowing bacteria to cross and activating an inflammatory immune response that alters the composition of the microbiome.
Chronic stress induces a decrease in the number of tight junction proteins, causing the lining to become more permeable and allowing pathogens to move out of the gut.
This decreases the abundance of several beneficial gut bacteria, which changes the composition of the microbiome and reduces its diversity. We understand the importance of actionable and sustainable lifestyle changes when it comes to improving gut health. To counter these effects, consider incorporating lifestyle practices that reduce stress, such as yoga, spending time in nature, exercising, and meditation.
Specific bacterial genera, such as Akkermansia, Lactococcus , and Oscillospira, have been found to be more abundant in people who are very social. Research into possible effects of bacterial diversity on behavior may help guide the development of new probiotic and prebiotic therapies for treating mental health conditions such as anxiety and depression.
Over the last few decades, the prevalence of autoimmune diseases such as celiac disease has risen and may be linked to increased consumption of gluten, which is very common in Western diets. Some research suggests that gliadin, the component of gluten that stimulates an immune response, increases permeability across the gut barrier.
Research has also found that gluten-containing diets can alter the gut microbiome and contribute to dysbiosis. Chronic inflammation is closely linked with many autoimmune diseases. Food allergies, sensitivities, or intolerance may cause inflammation in the gut lining and lead to a multitude of symptoms.
Exclusion diets are often recommended to confirm an allergy, sensitivity, or intolerance, and identified foods are then avoided. At WellTheory, our experienced Nutritional Therapy Practitioners can help you to identify and navigate trigger foods through specialized diets such as the Autoimmune Protocol.
Learn more about our approach here. Food sensitivities cause immune reactions that may be uncomfortable but not life-threatening.
This kind of reaction to food may resolve over time as the composition of the gut microbiome evolves. Food intolerance is when the digestive system is unable to digest or break down food. Food intolerances are typically related to the amount of a particular food you eat — some people may be able to avoid digestive reactions when a small amount of a problem food is consumed, but will experience symptoms of food intolerance if they eat a larger amount.
A food allergy is an inappropriate immune response to something most people eat with no problem. One of the most surprising observations of the past decade is that immune responses in sites distant from the gut can also be regulated by gut microbiota, as in the case of autoimmune uveitis, a sterile inflammatory disorder affecting the retina and uvea.
TJ dysfunction allows the interaction between host and environment to take place, new therapeutic strategies for autoimmune diseases should be aimed at reestablishing the intestinal barrier function through nutrition and diet. Studies have shown that the gut microbiome can shift over a short period of time following dietary changes.
Probiotic and other treatments that manipulate assemblage of the microbiome may offer methods of preventing or mitigating the effects of autoimmune disease. New insights into the mechanisms underlying autoimmune disease and the therapeutic strategies used to treat them continue to emerge in the scientific community.
Functional Medicine recognizes the triad of genetics, environmental triggers, and intestinal permeability as being at the forefront of autoimmune disease research, and in many ways, the Functional Medicine model is specifically designed to address these factors.
References Campbell AW. Autoimmunity and the Gut. Autoimmune Dis. doi: Autoimmune diseases. National Institute of Environmental Health Sciences.
Published November Accessed November 8, Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol.
Fasano A. Leaky gut and autoimmune diseases. Hiltensperger, V. Kumar, D. Zegarra-Ruiz, C. Dehner, N. Khan, F. Costa, E. Tiniakou, T. Greiling, W. Ruff, A. Barbieri, C. Kriegel, S. Mehta, J.
More ». Aufoimmune 27, The human gut harbors a complex community of microbes that autoi,mune many aspects of our health. Known as the gut Gut health and autoimmune diseases, these bacteria Detoxifying herbal extracts with diseaxes and maintaining a healthy immune system. The lining of the intestine forms a barrier that is crucial to containing gut microbes. If the lining is breached and a gut microbe is able to get into the bloodstream and nearby organs, it can cause disease. Despite the fact that the body has many ways to prevent the breach, microbes sometimes get through.
Ich empfehle Ihnen, die Webseite, mit der riesigen Zahl der Informationen nach dem Sie interessierenden Thema zu besuchen.
Nicht hat ganz verstanden, dass du davon sagen wolltest.